Drug labeling initiative BPA

Ended Awarded Last action

Contract number
75F40125F19007
Awardee
Awarding agency
Obligated
$1,747,919

Award facts

Contract value 100% obligated
$1,747,919.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B528 Special Studies/Analysis- Regulatory
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Arlington, VA 22209, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a BPA call to Deloitte Consulting LLP under the Drug Labeling Initiative BPA on January 17, 2025, with a ceiling value of $1,747,919.42. Performance occurs in Arlington, Virginia. The call, effective through January 30, 2026, is priced on a firm fixed price basis with no set-aside applied. Specific deliverables and detailed scope are not detailed in the available source material.

Quick answers

Who was awarded contract 75F40125F19007?

75F40125F19007 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on January 17, 2025.

How much is contract 75F40125F19007 worth?

The government has obligated $1,747,919 on 75F40125F19007.

Is contract 75F40125F19007 an order under another contract?

Yes. 75F40125F19007 is a BPA call under 75F40122A00018, a blanket purchase agreement.

Was contract 75F40125F19007 competed?

The extent of competition for 75F40125F19007 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award